Assessment of the effects of insulin secretagogues in humans.

Assessment of the effects of insulin secretagogues in humans.

Bibliographic Details
Main Authors:	Wallace, T, Matthews, DR
Format:	Journal article
Language:	English
Published:	2000

Similar Items

Berberine is an insulin secretagogue targeting the KCNH6 potassium channel
by: Miao-Miao Zhao, et al.
Published: (2021-09-01)

Adenylosuccinate Is an Insulin Secretagogue Derived from Glucose-Induced Purine Metabolism
by: Jessica R. Gooding, et al.
Published: (2015-10-01)

A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agen.
by: Kenji Sugawara, et al.
Published: (2016-01-01)

Circulating adipokines data associated with insulin secretagogue use in breast cancer patients
by: Zachary A.P. Wintrob, et al.
Published: (2017-02-01)

Author Correction: Berberine is an insulin secretagogue targeting the KCNH6 potassium channel
by: Miao-Miao Zhao, et al.
Published: (2021-10-01)

Assessing the Effect of Incretin Hormones and Other Insulin Secretagogues on Pancreatic Beta-Cell Function: Review on Mathematical Modelling Approaches
by: Giovanni Pacini, et al.
Published: (2022-05-01)

The growth hormone secretagogue receptor.
by: Korbonits, M, et al.
Published: (1999)

Correction: A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agent.
by: PLOS ONE Staff
Published: (2017-01-01)

Insulin secretagogue use and circulating inflammatory C–C chemokine levels in breast cancer patients
by: Zachary A.P. Wintrob, et al.
Published: (2017-04-01)

Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer
by: Zachary A.P. Wintrob, et al.
Published: (2017-04-01)

Dataset on granulopoiesis- and lymphopoiesis-stimulating cytokine levels in insulin secretagogue users with incident breast cancer
by: Zachary A.P. Wintrob, et al.
Published: (2017-04-01)

Symposium 19: Secretagogues: sulfonylureas and incretins
by: Víctor Commendatore
Published: (2020-11-01)

The assessment of insulin resistance in man.
by: Wallace, T, et al.
Published: (2002)

TH1 and TH2 cytokine data in insulin secretagogues users newly diagnosed with breast cancer
by: Zachary A.P. Wintrob, et al.
Published: (2017-04-01)

Neuroprotective actions of ghrelin and growth hormone secretagogues
by: Laura M. Frago, et al.
Published: (2011-09-01)

Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels
by: John T. Sigalos, et al.
Published: (2017-11-01)

Mutational analysis of ghrelin and the growth hormone secretagogue receptor
by: Gueorguiev, M, et al.
Published: (2004)

Rapid desensitisation of the GH secretagogue (ghrelin) receptor to hexarelin in vitro.
by: Orkin, R, et al.
Published: (2003)

Growth hormone secretagogues: history, mechanism of action, and clinical development
by: Junichi Ishida, et al.
Published: (2020-01-01)

The synthesis of a small library of prospective growth hormone secretagogues
by: JELENA JOKSIMOVIC, et al.
Published: (1999-10-01)

Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway.
by: Dalle, S, et al.
Published: (1999)

Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
by: Maria Mirabelli, et al.
Published: (2021-03-01)

Phytochemical Investigation of <i>Lepionurus sylvestris</i> Blume and Their Anti-Diabetes Effects via Anti-Alpha Glucosidase and Insulin Secretagogue Activities Plus Molecular Docking
by: Sathianpong Phoopha, et al.
Published: (2023-08-01)

Similar proportional, in spite of differing absolute responses to non-glucose and glucose insulin secretagogues in Type 2 diabetic, LADA and non-diabetic subjects
by: Meston, N, et al.
Published: (2007)

Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
by: Korbonits, M, et al.
Published: (1998)

Nutrient-sensing growth hormone secretagogue receptor in macrophage programming and meta-inflammation
by: Da Mi Kim, et al.
Published: (2024-01-01)

Biological activity in vitro and in vivo of an in silico designed secretagogue peptide to be used in fish
by: Rebeca Martínez, et al.

The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors.
by: Korbonits, M, et al.
Published: (2001)

The Ghrelin/Growth Hormone Secretagogue Receptor System Is Involved in the Rapid and Sustained Antidepressant-Like Effect of Paeoniflorin
by: Yuan Zhang, et al.
Published: (2021-02-01)

In vitro anti-diabetic activity, bioactive constituents, and molecular modeling studies with sulfonylurea receptor1 for insulin secretagogue activity of seed extract of Syzygium cumini (L.)
by: Meharban Assan Aliyar, et al.
Published: (2021-07-01)

A genetic study of the ghrelin and growth hormone secretagogue receptor (GHSR) genes and stature.
by: Gueorguiev, M, et al.
Published: (2009)

LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue
by: Kripa Shankar, et al.
Published: (2021-11-01)

EFFICACY AND SAFETY OF INTESTINAL SECRETAGOGUES FOR CHRONIC CONSTIPATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
by: Juan Sebastian LASA, et al.
Published: (2018-08-01)

Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database
by: Detournay B, et al.
Published: (2015-07-01)

The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants.
by: Korbonits, M, et al.
Published: (1999)

Digestive α-L-fucosidase activity in Rhodnius prolixus after blood feeding: effect of secretagogue and nutritional stimuli
by: Maiara do Valle Faria Gama, et al.
Published: (2023-07-01)

The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
by: Korbonits, M, et al.
Published: (1999)

Potent achiral agonists of the growth hormone secretagogue (ghrelin) receptor. Part 2: Lead optimisation.
by: Witherington, J, et al.
Published: (2008)

Potent achiral agonists of the ghrelin (growth hormone secretagogue) receptor. Part I: Lead identification.
by: Heightman, T, et al.
Published: (2007)

Development and Characterization of an F-labeled Ghrelin Peptidomimetic for Imaging the Cardiac Growth Hormone Secretagogue Receptor
by: Ahmed Abbas MSc, et al.
Published: (2018-11-01)